- Filed
- Mar 18, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 100 sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $684M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $2.96B |
| Current Assets | FY 2024 · Dec 31, 2023 | $696.9M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $4.76B |
| Capex | FY 2024 · Dec 31, 2022 | $482.8M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | $322M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2022 | $7.7M |
| Sga Expense restated | FY 2024 · Dec 31, 2022 | $244.3M |
| Net Income | FY 2024 · Dec 31, 2022 | −$130.9M |
| Operating Income restated | FY 2024 · Dec 31, 2022 | −$86.1M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2022 | $518.2M |
| Revenue restated | FY 2024 · Dec 31, 2022 | $1.09B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $1.69B |